Induction of tumour cell lysis by a bispecific antibody recognising epidermal growth factor receptor (EGFR) and CD3.

[1]  J. Karbach,et al.  Induction of tumor‐cell lysis by bi‐specific antibody recognizing ganglioside GD2 and T‐cell antigen CD3 , 1993, International journal of cancer.

[2]  J. Baselga,et al.  Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha. , 1992, Cancer research.

[3]  B. Gusterson,et al.  Dipeptidyl peptidase iv expression identifies a functional sub‐population of breast fibroblasts , 1992, International journal of cancer.

[4]  W. Dippold,et al.  Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  S. Canevari,et al.  Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules. , 1992, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[6]  K. Meyer zum Büschenfelde,et al.  T cell responses to human malignant tumours. , 1992, Cancer surveys.

[7]  A. Lanzavecchia,et al.  Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study. , 1992, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[8]  V. Zurawski,et al.  Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model. , 1991, Cancer research.

[9]  D. Segal,et al.  Bispecific antibodies and targeted cellular cytotoxicity. , 1991, Immunology today.

[10]  S. Gillies,et al.  Targeting human cytotoxic T lymphocytes to kill heterologous epidermal growth factor receptor-bearing tumor cells. Tumor-infiltrating lymphocyte/hormone receptor/recombinant antibody. , 1991, Journal of Immunology.

[11]  L. Weiner,et al.  Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes. , 1990, Cancer research.

[12]  R. Vessella,et al.  Heteroconjugate antibody-directed killing of autologous human renal carcinoma cells by in vitro-activated lymphocytes. , 1990, Journal of immunology.

[13]  K. Okumura,et al.  Preliminary trial of specific targeting therapy against malignant glioma , 1990, The Lancet.

[14]  W. Linehan,et al.  Epidermal growth factor receptor gene analysis in renal cell carcinoma. , 1990, The Journal of urology.

[15]  C. Cordon-Cardo,et al.  Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. , 1989, Cancer research.

[16]  T. Boon,et al.  Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Fleuren,et al.  Induction of tumor‐cell lysis by bi‐specific monoclonal antibodies recognizing renal‐cell carcinoma and cd3 antigen , 1989, International journal of cancer.

[18]  D. Strayer,et al.  Inhibition of epidermal growth factor-induced cellular proliferation. , 1987, The American journal of pathology.

[19]  M. Herlyn,et al.  Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. , 1987, Cancer research.

[20]  K. Zoon,et al.  Modulation of epidermal growth factor receptors by human alpha interferon. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. Gusterson,et al.  Over‐expression of the EGF receptor is a hallmark of squamous cell carcinomas , 1986, The Journal of pathology.

[22]  D. Segal,et al.  Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies , 1986, The Journal of experimental medicine.

[23]  P F Davison,et al.  Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments. , 1985, Science.

[24]  M N Pollak,et al.  MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. , 1985, Biochemical and biophysical research communications.

[25]  Osami Kanagawa,et al.  Hybrid antibodies can target sites for attack by T cells , 1985, Nature.

[26]  T. Libermann,et al.  Expression of epidermal growth factor receptors in human brain tumors. , 1984, Cancer research.